About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker INCY

Latest patent grants
GrantedPatentOwnerTypeSource
Oct 13, 202612760022
Tricyclic urea compounds as JAK2 V617F inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Sep 29, 202612747292
Anti-tumor combination therapy comprising anti-CD19 antibody and gamm…
INCY
Incyte Corporation
utilityGoogle Patents ↗
Sep 15, 202612735424
Fused pyrazine derivatives as A2A / A2B inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Aug 4, 202612698326
Anti-CD19 antibody formulations
INCY
Incyte Corporation
utilityGoogle Patents ↗
Jul 28, 202612692276
Tricyclic triazolo compounds as DGK inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Jun 2, 202612643881
Bicyclic amine CDK12 inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Jun 2, 202612642802
Topical formulations of ruxolitinib with an organic amine pH adjustin…
INCY
Incyte Corporation
utilityGoogle Patents ↗
May 19, 202612631639
Methods for predicting therapeutic benefit of anti-CD19 therapy in pa…
INCY
Incyte Corporation
utilityGoogle Patents ↗
May 12, 202612622908
Topical formulation for a JAK inhibitor
INCY
Incyte Corporation
utilityGoogle Patents ↗
May 12, 202612622908
Topical formulation for a JAK inhibitor
INCY
Incyte Corporation
utilityGoogle Patents ↗
Apr 14, 202612600723
Tetracyclic compounds as DGK inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Apr 14, 202612600722
Tetracyclic compounds as DGK inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Apr 14, 202612600717
Tricyclic compounds as inhibitors of KRAS
INCY
Incyte Corporation
utilityGoogle Patents ↗
Mar 31, 202612589096
Ruxolitinib formulation for reduction of itch in atopic dermatitis
INCY
Incyte Corporation
utilityGoogle Patents ↗
Mar 3, 202612564593
Topical formulation for a JAK inhibitor
INCY
Incyte Corporation
utilityGoogle Patents ↗
Mar 3, 202612564593
Topical formulation for a JAK inhibitor
INCY
Incyte Corporation
utilityGoogle Patents ↗
Feb 17, 202612552804
Tricyclic heterocycles as FGFR inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Feb 17, 202612552792
Solid forms of an FGFR inhibitor and processes for preparing the same
INCY
Incyte Corporation
utilityGoogle Patents ↗
Feb 17, 202612551485
Topical formulations of ruxolitinib with an organic amine pH adjustin…
INCY
Incyte Corporation
utilityGoogle Patents ↗
Feb 10, 202612544381
Topical formulation for JAK inhibitor
INCY
Incyte Corporation
utilityGoogle Patents ↗
Feb 10, 202612544381
Topical formulation for JAK inhibitor
INCY
Incyte Corporation
utilityGoogle Patents ↗
Jan 27, 202612534463
Substituted tricyclic compounds as FGFR inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Jan 27, 202612534463
Substituted tricyclic compounds as FGFR inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Jan 6, 202612516065
Tertiary alcohols as PI3K-γ inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Jan 6, 202612516059
Pyrazolopyridine compounds and uses thereof
INCY
Incyte Corporation
utilityGoogle Patents ↗
Jan 6, 202612516044
Heterocyclic compounds as immunomodulators
INCY
Incyte Corporation
utilityGoogle Patents ↗
Dec 16, 202512498382
Biomarkers for vitiligo
INCY
Incyte Corporation
utilityGoogle Patents ↗
Dec 9, 202512491244
Pharmaceutical combinations for treating tumor comprising anti-CD19 a…
INCY
Incyte Corporation
utilityGoogle Patents ↗
Nov 25, 202512479851
Process and intermediates for preparing a JAK inhibitor
INCY
Incyte Corporation
utilityGoogle Patents ↗
Nov 18, 202512473286
Salts of an FGFR inhibitor
INCY
Incyte Corporation
utilityGoogle Patents ↗
Nov 11, 202512466828
Bicyclic amines as CDK2 inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Nov 11, 202512466822
Heterocyclic compounds as immunomodulators
INCY
Incyte Corporation
utilityGoogle Patents ↗
Nov 11, 202512466815
Carboxamide compounds and uses thereof
INCY
Incyte Corporation
utilityGoogle Patents ↗
Nov 4, 202512459943
Crystalline solid forms of a BET inhibitor
INCY
Incyte Corporation
utilityGoogle Patents ↗
Oct 21, 202512448448
Anti-PD-1 antibodies and uses thereof
INCY
Incyte Corporation
utilityGoogle Patents ↗
Oct 14, 202512441742
Naphthyridine compounds as inhibitors of KRAS
INCY
Incyte Corporation
utilityGoogle Patents ↗
Oct 14, 202512441731
Pyrazolopyrimidine compounds and uses thereof
INCY
Incyte Corporation
utilityGoogle Patents ↗
Oct 14, 202512441727
Tricyclic compounds as inhibitors of KRAS
INCY
Incyte Corporation
utilityGoogle Patents ↗
Oct 14, 202512440495
Combination therapy for treatment of myeloproliferative neoplasms
INCY
Incyte Corporation
utilityGoogle Patents ↗
Sep 30, 202512428426
Process and intermediates for preparing a JAK1 inhibitor
INCY
Incyte Corporation
utilityGoogle Patents ↗
Sep 30, 202512428420
Tricyclic heterocycles as FGFR inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Sep 30, 202512427154
Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b]…
INCY
Incyte Corporation
utilityGoogle Patents ↗
Sep 30, 202512427154
Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b]…
INCY
Incyte Corporation
utilityGoogle Patents ↗
Sep 23, 202512421197
Aminopyrazine derivatives as PI3K-γ inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Sep 16, 202512415809
Pyrrolotriazine compounds as tam inhibitors
INCY
Incyte Corporation
utilityGoogle Patents ↗
Sep 2, 202512404272
Process for making a PD-1/PD-L1 inhibitor and salts and crystalline f…
INCY
Incyte Corporation
utilityGoogle Patents ↗
Aug 26, 202512396993
Ruxolitinib formulation for reduction of itch in atopic dermatitis
INCY
Incyte Corporation
utilityGoogle Patents ↗
Aug 12, 202512384778
Pyrazolopyridine compounds and uses thereof
INCY
Incyte Corporation
utilityGoogle Patents ↗
Aug 12, 202512383541
ALK2 inhibitors for the treatment of anemia
INCY
Incyte Corporation
utilityGoogle Patents ↗
Aug 5, 202512378243
Quinoline compounds as inhibitors of KRAS
INCY
Incyte Corporation
utilityGoogle Patents ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:08 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances